Immediate Impact
22 standout
Citing Papers
New clinical trial design in precision medicine: discovery, development and direction
2024 Standout
Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancer
2024 Standout
Works of Eva Guerra being referenced
Efficacy of subsequent therapies in patients (pts) with advanced ovarian cancer (AOC) in the phase III PAOLA-1/ENGOT-ov25 trial according to whether disease progression occurred during or after the end of olaparib (ola) maintenance.
2023
SIENDO/ENGOT-EN5/GOG-3055: A randomized phase 3 trial of maintenance selinexor versus placebo after combination platinum-based chemotherapy in advanced or recurrent endometrial cancer.
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Eva Guerra | 78 | 61 | 23 | 27 | 21 | 133 | |
| Н. В. Коваленко | 84 | 47 | 25 | 45 | 25 | 164 | |
| Anna Pawłowska | 114 | 69 | 16 | 102 | 18 | 215 | |
| Cunjian Yi | 41 | 28 | 17 | 18 | 23 | 180 | |
| Sarah Bétrian | 58 | 53 | 25 | 7 | 25 | 169 | |
| Qingyi Wang | 58 | 11 | 18 | 33 | 24 | 151 | |
| Daliah Tsoref | 59 | 51 | 23 | 16 | 15 | 165 | |
| Elena Giudice | 119 | 66 | 22 | 28 | 27 | 203 | |
| Fengxia Xue | 26 | 28 | 14 | 16 | 22 | 173 | |
| Justin Harold | 66 | 35 | 26 | 31 | 17 | 166 | |
| Yasuo Nakata | 47 | 48 | 35 | 8 | 25 | 194 |
All Works
Loading papers...